|
WO2020217472A1
|
|
Medicinal composition for preventing or treating treatment-resistant cancer
|
|
JP2019166246A
|
|
Endoscope system
|
|
EP3239711A2
|
|
Method for measuring anti-drug antibody
|
|
JP2018126235A
|
|
Endoscope apparatus
|
|
JP2018126237A
|
|
Endoscope apparatus
|
|
JP2018126236A
|
|
Endoscope device
|
|
WO2017187656A1
|
|
Assay method for anti-drug antibodies
|
|
TW201620551A
|
|
Stent of drug-dissolution type
|
|
WO2016009704A1
|
|
Medical treatment tool
|
|
WO2016009703A1
|
|
Medical treatment tool and treatment unit thereof
|
|
WO2015050102A1
|
|
Endoscope
|
|
WO2015050101A1
|
|
Endoscope
|
|
JP2016202192A
|
|
Rigid endoscope
|
|
JP2014113243A
|
|
Endoscope and drape, and endoscopic apparatus
|
|
AU2007246210A1
|
|
Marrow fluid sampling set and marrow needle
|
|
JP2008118989A
|
|
Pca2501 gene
|
|
JP2010280569A
|
|
Cxcl10 production inhibitor
|
|
JP2008178468A
|
|
Bone marrow drill
|
|
EP1975244A1
|
|
Method for measuring cholesterol in remnant-like lipoprotein
|
|
CA2589459A1
|
|
Method of measuring cholesterol in remnant-like lipoproteins
|
